NLCA & Local Data Comparison
Male:Female
1.4:1
0.84:1
Histology
68%
87%
Stage 4 at Presentation
32%
53%
Active Treatment Received
51%
87%
Resection in NSCLC
14%
18%
Median NSCLC survival
232
246